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Abstract : INTRODUCTION : Diabetic Nephropathy (DN) is the leading reason of all excess death-rate over type-2 
diabetes mellitus (T2DM) patients with microalbuminuria, macroalbuminuria or end-stage renal disease. This 
work was aimed to estimate insulin resistance (IR) effect on some markers and trace elements (Selenium, Zinc, 
Magnesium) levels for early predicting of DN in T2DM patients. METHODS : We conducted a cross-sectional clin-
ical study. Blood and urine samples were collected from 63 subjects with T2DM and 33 healthy controls to assess 
glucose, insulin, IR, urea, creatinine, glomerular filtration rate (GFR), creatinine clearance (CrCl), homocysteine 
(Hcy), fructosamine (FA), cystatin C (CysC), albumin (Alb), neutrophil gelatinase-associated lipocalin (NGAL), 
8-hydroxy-2`-deoxyguanosine (8-OHdG) and trace elements levels. Data were collected using a questionnaire 
that was filled out by specialized doctors. RESULTS : Compared with controls, the results revealed that T2DM 
patients with or without DN had significant increases in glucose, insulin, IR, urea, creatinine, Hcy, FA, CysC, 
Alb, NGAL and 8-OHdG and significant decreases in GFR, CrCl and trace elements levels. Body mass index (BMI) 
had no changes. CONCLUSION : Uncontrolled T2DM was associated with BMI, IR and physical activity in which 
elevated Hcy, FA, CysC, Alb, NGAL and 8-OHdG levels and decreased trace elements levels may be used as early 
clinical markers of DN. J. Med. Invest. 68 : 76-84, February, 2021
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INTRODUCTION
 
The term of insulin resistance (IR) is elucidated the disability 
of cells response to the insulin action in transferring glucose 
from the bloodstream into muscle and tissues (1, 2). Diabetes 
mellitus (DM) is still an important health problem as rising 
numbers of patients with chronic and badly preserved diabetes 
develop diabetic nephropathy (DN) (3, 4).
DN is classically defined by the existence of proteinuria in 
the non-attendance of other renal disease. It is a common issue 
that is usually happen in patients who have hypertension, bad 
glycemic control, genetic predisposition or glomerular hyperfil-
tration (5). DN is may be representing a crucial cause of chronic 
kidney disease (CKD) that customarily leads to end-stage renal 
disease (ESRD) (6, 7). Urine albumin excretion (UAE) is deemed 
normal (normoalbuminuria) when it is less than 30 mg / day (2-19 
μg / mL). Also, UAE is classified as microalbuminuria (MAU) 
when it reaches 30-300 mg / day, macroalbuminuria when it ex-
ceeds 300 mg / day (8, 9).
Considering the raised happening of both DM and DN, the 
detection of early DN is fundamental importance to supply 
suitable therapy that prevents or slows evolution towards ESRD. 
Markers have a crucial role in the first detection of DN. These 
markers span period of normoalbuminuria that predates MAU 
but also development of renal involvement during MAU or mac-
roalbuminuria (10).
Homocysteine (Hcy) is a homologue of the amino acid cyste-
ine differing by an extra methylene (-CH2-) group. Hcy is not 
acquired from the food, but it is biosynthesized from methionine 
via a multi-step process. Hcy raised oxidant stress-triggered 
vascular dysfunction and the inverse impacts of Hcy on vascular 
function and neuroexcitation may participate in the developing 
and progress of dementia-type disorders (11).
Fructosamine (FA) is a compound resulting from the reaction 
between fructose and amine (with a molecule of water being 
released) and utilizing to recognize the plasma glucose level over 
time and assess diabetic control over an intermediate period 
since FA assessment exploits the capability of serum proteins 
to go through glycation (glycosylation) in situations of elevated 
ambient glycemia (12).
Cystatin C (CysC) is a low molecular weight protein produced 
at a stable rate by all nucleated cells. CysC is encoded by the 
CST3 gene and fundamentally used as a biomarker for kidney 
function and might play a role in brain disorder and an inhibitor 
of papain-like cysteine proteases. CysC has lately been shown in-
hibition to other family of cysteine protease called the peptidase 
family C13 with human legumain as a model enzyme (13).
Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a 
small protein, almost 25kD, that belongs to a superfamily of 
proteins called lipocalins which is a family from small proteins 
that cells send out to tie up things and convey them back and 
particularize in binding and carrying small hydrophobic mol-
ecules. NGAL possess varied functions like : motivating apop-
tosis, transferring, adjusting immune response and triggering 
nephrogenesis by inducing the diversion of mesenchymal cells 
to kidney epithelia. Also, NGAL plays a reno-protective function 
via promoting tubule cell proliferation in kidney injury particu-
larly in ischemia-reperfusion injury (14).
8-Hydroxy-2`-deoxyguanosine (8-OHdG) is an output of ox-
idative DNA damage following specified enzymatic cleavage 
after reactive oxygen species (ROS) stimulated 8-hydroxylation 
of the guanine base in nuclear DNA and mitochondria. When 
impaired DNA is fixed, 8-OHdG is secreted in urine without 
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further metabolism. 8-OHdG can be found in tissues, blood and 
urine of humans and it is considered an authoritative and key 
marker for cellular oxidative stress (15).
Although the scientific community has started resolving the 
secrets of the close linkage between IR, some blood and urine 
markers with trace elements and their physiological effects, a 
lot is still remaining to be discovered. In the province of Basrah 
(southern of Iraq), to date, no study has been investigated on IR, 
Hcy, FA, CysC, NGAL, 8-OHdG and trace elements (Selenium 
[Se], Zinc [Zn] and Magnesium [Mg]) and their effects on DN 
patients. Therefore, the present study is focused on assessing the 
IR effect on these markers and trace elements levels in DN pa-
tients in Basrah province-Iraq to obtain useful results that can 
be adopted in early diagnosis of DN in T2DM patients. 
PATIENTS AND METHODS
Subjects
The present study is a cross-sectional clinical experiment that 
investigated the IR impact on DN markers in T2DM subjects. 
Samples were collected from the subjects who were visiting 
“Diabetes and Endocrine Glands Centre” at Al-Mawany teach-
ing hospital in Basrah province-Iraq, during the period from 
August 2019 until February 2020.
In this study, 63 subjects (men and women) who suffering from 
T2DM were selected to share in this study and they divided into 
two groups : the first group was 31 patients who suffering from 
DN (15 men and 16 women) while the second group was 32 pa-
tients who free from DN (15 men and 17 women). These subjects 
were matched with 33 healthy controls (16 men and 17 women).
Patients with the following inclusion criteria were shared in 
the current study ; age between 36-65 years old ; T2DM patients 
(with or without DN) were diagnosed by clinicians in the diabe-
tes and endocrine glands centre in Al-Mawany teaching hospi-
tal. The control group was health individuals, not suffering from 
T2DM nor having any family history of T2DM, not suffering 
from any acute or chronic cardiovascular diseases (CVD’s) and 
not taking any drugs believed to alter plasma glucose level. All 
the volunteers had a stable clinical course for at least 3 months.
Patients who were pregnant (women), had angina or heart 
failure, pancreatic diseases, hypertension, renal failure, severe 
liver dysfunction, alcoholics, T1DM, urinary tract infection, un-
controlled thyroid disorders, human immunodeficiency viruses 
(HIV) infections, hormonal abnormalities, genetic syndromes 
and severe concurrent illness were excluded from the study.
Diagnosis of T2DM patients was based on the recommenda-
tions of American Diabetes Association (16). DN was diagnosed 
based on GFR level ( < 60 mL / min / 1.73m2) or persistent micro-
albuminuria ( > 19 μg / mL) in the morning urine of patients (17, 
18). Demographical data were collected via a structural inter-
view that was conducted during the visit. Standard self-admin-
istered questionnaire paper is used to define the age, duration of 
DM and DN, health habits (smoking, alcohol consumption and 
exercise), medical history and current medications. 
Sampling procedures
All samples were collected in the morning between 09:00-
10:00 AM after 12 hours fasting time and 30 minutes of rest in 
the supine position.
Fresh venous blood (10 mL) was collected from all volunteers 
by vein punch then divided into two parts : the first part (1 mL) 
was added into special tube with anticoagulant and shook gently 
as a whole blood to utilize for Se level determination. The second 
part (9 mL) was moved to plain tube (without anticoagulant) 
which admitted clotting for 20 minutes at room temperature. 
Then, it was moved into a centrifuge at 402 × g for 20 minutes 
to get the serum.
Also, Fresh morning urine (20 mL) was collected from all vol-
unteers in pre-sterile vials, after first voids of urine, the sample 
was centrifuged at 402 × g for 20 minutes to remove all suspend-
ed particles. Then, the clear supernatant was collected carefully.
All the collected samples (whole blood, serum and urine) were 
immediately utilized in the estimation of the variables in this 
study, while the rest were stored in deep freezing at (-80°C) until 
using.
Clinical and laboratory measurements 
Serum glucose, urea and creatinine were determined by UV-
Vis Spectrophotometer (UV-EMC-LAB, Duisburg, Germany) 
and using the following kits (Randox, County Antrim, UK, Cat. 
No. : GL364 ; Linear, Barcelona, Spain, Cat. No. : 1156015 ; Randox, 
County Antrim, UK, Cat. No. : CR 511 / S) respectively.
Serum (insulin, Hcy, FA and CysC) and urine (Alb, NGAL 
and 8-OHdG) markers were assayed by human ELISA kits 
(Calbiotech, California, USA, Cat. No. : IS130D ; BT-Lab, Shang-
hai, China, Cat. No. : E3292Hu ; BT-Lab, Shanghai, China, Cat. 
No. : E3232Hu ; BT-Lab, Shanghai, China, Cat. No. : E1104Hu ; 
Creative Diagnostics, New York, USA, Cat. No. : DEIA2299 ; BT-
Lab, Shanghai, China, Cat. No. : E1719Hu ; BT-Lab, Shanghai, 
China, Cat. No. : EA0048Hu), respectively. Sandwich ELISA 
technique was applied, and the level of each biomarker was as-
sayed using a standard curve.
Blood trace elements estimation
Serum Zn and Mg were determined by using GBC 933 Plus 
flame atomic absorption spectrometry “FAAS” (GBC, Braeside, 
Australia) (19).
While, whole blood Se was determined by Flame Atomic 
Absorption Spectrometer with Homemade Hydride Generation 
System (Shimadzu, Tokyo, Japan) (20).
Clinical parameters calculations
Body mass index (BMI) was calculated by the standard BMI 
equation (21) : 
BMI (kg / m2) = weight (kg) / height (m2)
IR was calculated by the Homeostatic Model Assessment for 
Insulin Resistance (HOMA-IR) equation (22) : 
HOMA-IR = Fasting insulin (μIU / mL) × Fasting glucose 
(mg / dL) / 405
Glomerular filtration rate (GFR) was calculated by the Modi-
fication of Diet in Renal Disease Study (MDRD) equation (23) :  
GFR (mL / min / 1.73 m2) = 186 × Serum Cr-1.154 × age-0.203 × 
1.212 (if subject is black) × 0.742 (if subject is female)
Creatinine clearance (CrCl) was calculated by the 
Cockcroft-Gault equation (23) : 
CrCl (mL / min) = (140 – age) × (weight in kg) × (0.85 if fe-
male) / (72 × Serum Cr)
Statistical Analysis
Statistical analysis of data was carried out using statistical 
package for the social sciences (SPSS) and the values expressed 
as mean ± SD. The values of p > 0.05 was to be considered sta-
tistically not significant, p < 0.05 was considered as significant 
differences and p < 0.01 for highly significant.
Ethical considerations
This study was conducted in accordance with the Declaration 
of Helsinki and the protocol of this study was approved by the 
Ethics and Behavioural Research Committee (Scientific Com-
mittee) in the Department of Chemistry – College of Science – 
University of Basrah – Basrah – Iraq. The procedures were fully 
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clarified to all subjects and an informed consent form was signed 
and obtained from all the participants.
RESULTS
The general demographic characteristics of all volunteers par-
ticipated in this work were presented in Table 1.
As compared to healthy controls, the results revealed that 
T2DM patients with or without DN had a non-significant change 
(p > 0.05) in BMI level, as shown in Table 2.
On the other hand, data obtained in our study (in Tables 2 and 
4) indicated that T2DM patients with or without DN had a high 
significant (p < 0.01) increase in levels of serum (glucose, insu-
lin, HOMA-IR, Hcy and FA) and urine (NGAL and 8-OHdG) 
markers as compared to healthy group.
Furthermore, T2DM patients with DN had a high significant 
increase (p < 0.01) and patients with T2DM without DN had 
a significant increase (p < 0.05) in the levels of serum urea, 
creatinine, CysC and urinary Alb as compared to controls, as 
demonstrated in Tables 2 and 4.
Moreover, our data reported that GFR and CrCl levels were 
decreased significantly in T2DM patients (p < 0.01 in patients 
with DN and p < 0.05 in patients without DN) as compared to 
controls, as illustrated in Table 2.
Finally, results in Table 3 revealed that the levels of blood trace 
elements (Se, Zn and Mg) were highly significantly (p < 0.01) de-




In the current study, data presented that all the patients and 
healthy control subjects were non-smokers. Also, most of the vol-
unteers from both patients and healthy control were from urban, 
all of them acquired a well-educated and they had a good work 
place. The major variations between populations of urban and 
rural regions are the differences in food habits, genetic, social, 
psychic, pollution, environments and others which are raising 
dramatically in urban areas (22).
Obesity may be representing a diabetogenic factor via ele-
vating resistance to the action of insulin in those genetically 
predisposed to enhance T2DM. So, it could be acts as one of 
the etiological factors in the development of T2DM, and mostly 
because of loss of early phase insulin secretion in response to 
glucose which happens relatively earlier in the development of 
T2DM (24). This loss is critically crucial as the early blast of in-
sulin secretion plays a substantial role in priming target tissues 
of insulin, especially the liver responsible for normal glucose 
homeostasis after food uptake and mealtime glucose deflection 
take place when this process was deteriorated (25). Further-
more, it may consider one of the modifiable cardiovascular risk 
factors that is far more predominant in those people with T2DM 
than in the general population. Moreover, obesity and physical 
inactivity are important independent risk factors for T2DM in 
middle aged of both men and women (26).
Insulin resistance (IR) can be known as a form of biological 
misinformation in the body in which the insulin hormone re-
ceptors on the cell membrane are not responding suitably to 
insulin. Thus, the glucose in blood becomes unable to reach 
into cells which could lead to a hypoglycaemic reaction. This 
condition makes the pancreas produces high doses of insulin 
to endeavour getting the glucose out of blood into cells. So, this 
leads to decrease in the ability of insulin to adjust and signal 
changes in the levels of glucose in the blood and perhaps grows 
IR (21). HOMA-IR was used as a substitute measure of IR in 
our study. Although HOMA-IR was not the gold standard for 
assessment of insulin sensitivity, but it was a clinically useful 
index in many studies (27). The function of β-cells may be dam-
aged during adolescence or later. Its deterioration ranges from 
hyperinsulinemia, secondary to IR, with normal glucose toler-
ance to β-cells failure with T1DM. Furthermore, when insulin 
secretion is decreased (IR is present) in the later stages of the 




with DN without DN
Total subjects No. 31 32 33
Age (Years) (Mean ± SD) 57.26 ± 4.47 53.94 ± 4.74 51.70 ± 5.07
DM duration (Years) (Mean ± SD) 13.57 ± 2.53 5.23 ± 1.66 -
DN duration (Years) (Mean ± SD) 6.80 ± 0.63 - -
Demographic
area
Urban 28 27 29
Rural 3 5 4
Educational 
background
Learned 25 24 26
Illiterate 6 8 7
Smoking
habits
Positive 0 0 0
Negative 31 32 33
Food
habits
Vegetarian 5 6 8
Non-vegetarian 26 26 25
Employment
status
Employed 19 14 28
Not employed 12 18 5
Gender
Men 15 15 16
Women 16 17 17
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Table 2.　Levels of serum markers in men and women of healthy control and T2DM patients with and without DN.
Marker Gender
T2DM Patients Healthy 
Controlwith DN without DN
Mean ± 
SD SE Range
95% CI Mean ± 
SD SE Range
95% CI Mean ± 
SDLower Upper Lower Upper
BMI
(Kg / m2)
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Data are presented as mean ± standard deviation (SD) ; SE : Standard error, Range : is the difference between the highest and lowest 
values in the set, 95% CI : Confidence intervals (Lower and Upper) ; significance level is indicated by *, Where: p > 0.05 : p-value not sig-
nificant, * indicates p < 0.05 (p-value significant) ; ** indicates p < 0.01 (p-value highly significant), in comparison with the correspond-
ing control value.
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disease, free fatty acids (FFA’s) are released in large amounts 
followed by an elevated production of glucose, triglycerides (TG’s) 
and very low-density lipoprotein (VLDL) (28). Also, FFA’s de-
creased insulin sensitivity in muscles by discouraging insulin 
mediated glucose uptake. It is obvious that IR causes rising in 
blood glucose and FFA’s levels, thus, worsening the IR and hy-
perglycemia with released FFA’s further rises insulin secretion 
(hyperinsulinemia) forming a wicked circle (29). Furthermore, 
some environmental factors, like the obesity epidemic due to the 
physical exercise lack and increased caloric intake, are obviously 
responsible for the present elevation in the incidence of the meta-
bolic syndrome worldwide (30). It has been speculated that TG’s 
accumulation in skeletal muscles plays a lineal role in the aetiol-
ogy of IR. So, chronic hyperglycemia and dyslipidemia in T2DM 
can both produce hurtful effects on β-cell structure and function 
(31, 32). Moreover, as DN progress, IR may be stimulating the 
decrease in renal function toward ESRD. High TG’s levels are a 
risk factor for proteinuria development and TG-rich apolipopro-
tein B-containing lipoproteins clearly promote the progression of 
renal insufficiency (33).
Our data revealed that urea and creatinine levels were in-
creased and GFR and CrCl levels were decreased in T2DM 
patients with and without DN when compared with controls (34).
Homocysteine (Hcy) is an amino acid created during the me-
tabolism of methionine. The significant elevation in Hcy level in 
T2DM patients with and without DN in our study maybe due to 
IR. IR has been speculated to play a crucial role in the enhance-
ment of atherosclerotic disease via dyslipidaemia, hypertension 
Table 3.　Levels of trace elements in blood in men and women of healthy control and T2DM patients with and without DN.
Biomarker Gender
T2DM Patients Healthy 
Controlwith DN without DN
Mean ± 
SD SE Range
95% CI Mean ± 
SD SE Range
95% CI Mean ± 
SDLower Upper Lower Upper
Se
(ng / mL)


























































Data are presented as mean ± standard deviation (SD) ; SE : Standard error, Range : is the difference between the highest and lowest 
values in the set, 95% CI : Confidence intervals (Lower and Upper) ; significance level is indicated by *, Where : p > 0.05 : p-value not sig-
nificant, * indicates p < 0.05 (p-value significant) ; ** indicates p < 0.01 (p-value highly significant), in comparison with the correspond-
ing control value.
Table 4.　Levels of urine markers in men and women of healthy control and T2DM patients with and without DN.
Biomarker Gender
T2DM Patients Healthy 
Controlwith DN without DN
Mean ± 
SD SE Range
95% CI Mean ± 
SD SE Range
95% CI Mean ± 
SDLower Upper Lower Upper
Alb
(μg / mL)


























































Data are presented as mean ± standard deviation (SD) ; SE : Standard error, Range : is the difference between the highest and lowest 
values in the set, 95% CI : Confidence intervals (Lower and Upper) ; significance level is indicated by *, Where : p > 0.05 : p-value not sig-
nificant, * indicates p < 0.05 (p-value significant) ; ** indicates p < 0.01 (p-value highly significant), in comparison with the correspond-
ing control value.
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and hyperglycemia (35). Hence, hyperhomocysteinemia boosts 
IR by stimulating elevating glucose output, endoplasmic retic-
ulum stress and upregulation phosphoenolpyruvate carboxyki-
nase (PEPCK). This mechanism leads to increase Hcy levels in 
blood which may spend an atherothrombotic effect via elevating 
oxidative stress which may motivate endothelial dysfunction 
(11). Hcy levels in T2DM patients can be affected by both glomer-
ular hyper- and hypofiltration which can respectively diminish 
and raise Hcy levels. Hcy is ultra-filtrated via the glomeruli and 
nearly fully reabsorbed in the tubules and degraded in renal 
tissue by transmethylation and transsulfuration. However, de-
creased GFR escorts MAU in the late phase of DN, and decreas-
ing of GFR causes increasing of Hcy levels (36).
Fructosamine (FA) is a ketoamine formed from the reaction 
between the carbonyl group of glucose and the amino group of 
protein. The significant increasing in FA level in T2DM patients 
with and without DN in our study could be due to protein losing 
states like diminished protein production, nephrotic syndrome, 
immunoglobulins, and physiologic or pathologic conditions as-
sociated to hypoproteinemia (12). It is possible that protein 
metabolism is modified in obese adults and could affected by 
inflammation. C-reactive protein (CRP) is known to be highly 
linked with BMI and is decreased by weight loss. There are other 
situations that may affect the interpretation of elevated FA levels 
include hyperuricemia, liver disease, acute illness and some in-
fections (28). Moreover, hyperglycemia could consider as another 
possible cause for the significant increasing in FA level in T2DM 
patients with and without DN. The risk of secondary complica-
tions in patients with T2DM is highly connected to the chronic 
level of blood glucose. Nonenzymatic glycosylation is promoted in 
hyperglycemic conditions and chronic complications attached to 
DM. The products of nonenzymatic glycation combine in renal 
tissues and play a pivotal role in DN (37).
Cystatin C (CysC), a 13 kD protein, is generated by a house-
keeping gene in all nucleated cells. The significant increasing in 
CysC level in T2DM patients with and without DN could be due 
to advancement of CKD from stages I to III. Also, rise in serum 
CysC confront progression from normoalbuminuria to MAU and 
thereby suggestive a positive correlation between serum CysC 
and albumin creatinine ratio (ACR). So, serum CysC is a useful 
indicator in early detection of DN as it reflects decreasing in 
GFR as well as rise in ACR (1). Moreover, there are another pos-
sible and acceptable explanations for this significant elevation in 
CysC level in T2DM patients with and without DN such as IR 
and inflammation, and this may explain the connection between 
CysC and cardiovascular disease (CVD) in T2DM (5). The sta-
bilized production rate of CysC and its lack of excretion by the 
tubular epithelial cells may indicated that the kidney function is 
the main determinant of CysC and even minimal kidney harm 
will result a significant increase in levels before the manifesta-
tion of traditional CKD markers (38). There is a chance of intro-
ducing CysC-based formulas without anthropometric variables 
to substitute creatinine-based equations in prediction GFR (39).
Selenium, a trace element, is a major component in glutathione 
peroxidase (GPx) which is one of the main antioxidant enzymes 
in the human body and responsible for preventing the production 
of free radicals, decreasing their activity or destroying them (19). 
Selenium levels were found significantly lower in T2DM patients 
with and without DN when compared to healthy control group. 
Selenium is known to work as an antioxidant and peroxynitrite 
scavenger when integrated into selenoproteins (20). This lack 
in Selenium levels may lead to oxidative stress, decline insulin 
secretion and elevate IR in some empirical models. Thereby, per-
haps taking a causal function in the forward and pathogenesis 
of T2DM. Moreover, elevated oxidative stress and glycosylation 
play a main pathogenic role in diabetic endothelial cell dysfunc-
tion in T2DM patients with and without DN (21).
Zinc is one of the fundamental trace elements which are in-
volved in the synthesis, secretion, conformational integrity and 
storage of insulin. Our study reported that Zinc levels in T2DM 
patients with and without DN were lower than the controls. In 
the mammalian pancreas, Zinc is fundamental for the correct 
processing, secretion, storage and action of insulin in β-cells 
(22). Insulin is stored in secretory sacs or granules, where two 
Zn2+ ions coordinate six insulin monomers to generate the hex-
americ form on which maturated insulin crystals are based. It 
is also known that many other chronic disorders like DM could 
decrease Zinc levels, for example, DM increases the excretion of 
minerals such as Zinc in urine or may decrease gastrointestinal 
absorption of Zinc (40). Also, Hyperglycemia in DM is often 
linked with hyperzincuria, which is of kidney origin, and raise 
urinary loss of Zn2+ and declines of its level in entire body Zn2+. 
Kidney tubular flaw in handling Zinc and glucose-induced, 
osmotic diuresis are other probabilities. Furthermore, Zinc may 
enhance glycaemia and a restored Zinc status in patients with 
T2DM (with or without DN) may oppose the harmful effects of 
oxidative stress which helping to prevent complication beneficial 
antioxidant effects in people with T2DM (19). Zinc has been il-
lustrated to have particularly importance in the light of the mis-
chievous outcomes of oxidative stress in subjects with DM. Zinc 
has antioxidant properties, thus, it can balance macromolecules 
against radical stimulated oxidation (20).
Magnesium is a trace element which is responsible for main-
taining some body functions. It is demanded for several enzymes’ 
activities and for neuromuscular transmission. It plays a key 
role in glucose metabolism. The hypomagnesaemia in T2DM 
patients with and without DN in our study may be due to poor 
dietary intake, elevated urinary loss because of hyperglycemia, 
impaired absorption of Mg, imperfect Mg reabsorption from kid-
ney tubules, osmotic diuresis and loss of plasma protein bound 
to Magnesium (21). Magnesium diminution is said to decrease 
the insulin sensitivity, thereby, raising the risk of secondary 
complications. Hyperglycemia leads to decline cellular Mg levels. 
Hypomagnesaemia leads to decrease function of Mg dependent 
enzymes, collagen and ADP-induced platelet convenience and 
oxidative stress (22). Moreover, insulin lack and resistance lead 
to decreased tubular reabsorption of Mg and resulted hypomag-
nesemia prefer the onset and development of diabetic microan-
giopathy via a decreasing in activity of Na+/ K+ ATPase pump. 
So, hypomagnesemia alone foretells the progression to ESRD in 
patients with advanced DN (40).
Neutrophil Gelatinase-Associated Lipocalin (NGAL) is a 
small protein that belongs to the lipocalin proteins family secret-
ed from neutrophils and several epithelial cell types including 
renal tubular cells. The significant elevation in NGAL level in 
T2DM patients with and without DN in our study could be due to 
acute kidney injury because NGAL is secreted by the kidney tu-
bules and usually filtered by the glomerulus (14). In case of renal 
injury, the production of NGAL is elevated while the absorption 
is decreased by the renal tubules resulting a raising in NGAL 
levels (41). Furthermore, elevated albumin levels could play a 
pivotal role in raising levels of NGAL in T2DM patients with and 
without DN in our study because it activates kidney proximal 
tubular epithelial cells to stimulate tubulointerstitial inflamma-
tion (42). In contrast, high glucose levels and diabetic substrates 
(such as advanced glycation end-products, ultra-filtered growth 
factors and carbonyl intermediates) could excite a number 
of signalling pathways to enhance tubular cell hypertrophy 
and the interstitial precipitation of growth factors, cytokines, 
chemokines and adhesion molecules which are able to motivate 
additional inflammation and fibrosis as well as the stimuli that 
encourage epithelial damage which leading to increase NGAL 
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levels (43).
8-Hydroxy-2`-deoxyguanosine (8-OHdG) is one of the main 
products of DNA oxidation. Levels of 8-OHdG within a cell could 
considered as a measurement of oxidative stress. Production 
of ROS and lipid peroxidation are elevated in diabetic patients 
particularly in those with poor glycemic control. Oxidative stress 
may be important for evolution of diabetic vascular complications 
(15). So, Intracellular ROS can cause strand breaks in DNA and 
base modifications which leading to elevate levels of 8-OHdG. 
From the other hand, oxidative damage yields 8-OHdG after the 
manifestation of specified enzymatic cleavage when ROS stim-
ulates 8-hydroxylation in mitochondrial and nuclear DNA (44). 
This progressive process clearly describes the connection be-
tween raised oxidative stress and T2DM and increased 8-OHdG 
secreted in urine synchronizes with high systemic DNA damage 
in patients with DN. Moreover, IR could play a pivotal role in 
producing oxidative stress, through free glucose activates aldose 
reductase activity and the polyol pathway, which could lead to 
decrease NADPH / NADP+ ratio (45). Increased intracellular 
glucose activates protein kinase C (PKC) via de novo synthesis 
of diacylglycerol. PKC stimulates oxidative stress by activating 
mitochondrial NADPH oxidase. So, the generated ROS may 
induce apoptosis, inflammation and endothelial dysfunction. Ex-
cess of FFA’s, also can elevate oxidant production by β-oxidative 
phosphorylation through mitochondrial metabolism. These 
mechanisms may lead to increase 8-OHdG levels significantly in 
T2DM patients with and without DN (46).
Based on our findings, we recommend that all T2DM patients 
should visit renal, optical, cardiovascular and neurological clin-
ics regularly to take early steps to avoid and manage diabetic 
complications such as DN, diabetic retinopathy, CVD and dia-
betic neuropathy. Furthermore, the above investigated clinical 
and biochemical markers must be used in the hospitals and 
clinics of Basrah province in the future as new markers for early 
detection of the development of vascular complications in T2DM 
patients especially DN. Moreover, DN is a huge health issue that 
requires an appropriate treatment strategy. Therefore, the Iraqi 
state must understand this issue and show interest to allocate 
the essential resources to treat it. The socio-economic and med-
ical support of patients (such as medical services, easier access 
to programs of health education, broader social support and 
higher insurance coverage) are crucial requirements for fixing 
this issue.
CONCLUSION
In conclusion, the results of this study demonstrate that obesi-
ty is a case accompanied by elevated levels of insulin and glucose 
which are the vigorous indicators for evaluation of the IR syn-
drome in diabetic patients especially with kidney disease. In ad-
dition, kidney disease is linked with the raising of IR, BMI levels 
in T2DM patients which had been observed via decreasing GFR, 
CrCl and increased urea, creatinine, Hcy levels. Furthermore, 
people who have T2DM (with or without DN) tend to have high 
levels of Hcy, FA which give an indicator on the significant differ-
ence in oxidant / antioxidants status and may suggest a probable 
another role of oxidative stress mechanism in pathophysiology 
of T2DM which lead to DN. Additionally, CysC and creatinine 
were significantly higher in patients with DN compared to with-
out DN. On the other hand, CysC may had a high significant 
diagnostic accuracy in distinguishing patients with DN than 
creatinine. Besides, the declining in some essential antioxidant 
trace elements levels (Selenium, Zinc and Magnesium) is a pow-
erful indicator for evaluation of the oxidative stress syndrome 
in diabetic patients with and without DN than non-diabetics. 
Moreover, urinary markers (Alb, NGAL and 8-OHdG) illustrat-
ed an excellent diagnostic value for early-stage of DN in patients 
with T2DM. Finally, Uncontrolled T2DM was associated with 
BMI, IR and physical activity in which the elevated levels of Hcy, 
FA, CysC, Alb, NGAL and 8-OHdG and decreased levels of trace 
elements may be used as early clinical markers of DN. 
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